全文获取类型
收费全文 | 427篇 |
免费 | 22篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 15篇 |
妇产科学 | 5篇 |
基础医学 | 49篇 |
口腔科学 | 7篇 |
临床医学 | 26篇 |
内科学 | 78篇 |
皮肤病学 | 2篇 |
神经病学 | 50篇 |
特种医学 | 33篇 |
外科学 | 47篇 |
综合类 | 4篇 |
预防医学 | 16篇 |
眼科学 | 66篇 |
药学 | 18篇 |
中国医学 | 5篇 |
肿瘤学 | 22篇 |
出版年
2023年 | 5篇 |
2022年 | 12篇 |
2021年 | 39篇 |
2020年 | 6篇 |
2019年 | 18篇 |
2018年 | 27篇 |
2017年 | 13篇 |
2016年 | 16篇 |
2015年 | 21篇 |
2014年 | 26篇 |
2013年 | 39篇 |
2012年 | 44篇 |
2011年 | 29篇 |
2010年 | 18篇 |
2009年 | 8篇 |
2008年 | 21篇 |
2007年 | 13篇 |
2006年 | 15篇 |
2005年 | 13篇 |
2004年 | 4篇 |
2003年 | 11篇 |
2002年 | 5篇 |
2001年 | 3篇 |
2000年 | 10篇 |
1999年 | 4篇 |
1998年 | 2篇 |
1997年 | 1篇 |
1996年 | 2篇 |
1995年 | 1篇 |
1993年 | 3篇 |
1992年 | 2篇 |
1991年 | 1篇 |
1990年 | 2篇 |
1989年 | 4篇 |
1986年 | 3篇 |
1985年 | 1篇 |
1977年 | 1篇 |
1976年 | 2篇 |
1966年 | 1篇 |
1962年 | 2篇 |
1961年 | 1篇 |
排序方式: 共有449条查询结果,搜索用时 359 毫秒
441.
442.
443.
444.
Glycodelin A triggers mitochondrial stress and apoptosis in T cells by a mechanism distinct and independent of TCR signaling 总被引:1,自引:1,他引:0
Glycodelin A is one of the progesterone inducible endometrial factors that protect the fetal semiallograft from maternal immune rejection. Our previous studies demonstrate that glycodelin A induces apoptosis in activated T lymphocytes. Here, we report that glycodelin A initiates the intrinsic apoptotic program in T cells. Glycodelin A treatment triggers a stress response leading to mitochondrial membrane permeabilization and activation of initiator caspase 9. The kinetics of mitochondrial depolarization precede onset of DNA fragmentation in both Jurkat cells and peripheral blood T cells treated with glycodelin A. Overexpression of the antiapoptotic protein Bcl-2 is sufficient to protect from glycodelin A-induced cell death. It has been reported earlier that glycodelin A desensitizes T cell receptor (TCR) signaling, probably by its association with the tyrosine phosphatase CD45. Here, we provide evidence that the apoptogenic activity of glycodelin A is not a consequence of this phenomenon. Glycodelin A-induced apoptosis does not depend on components of the TCR signal cascade, including CD45. We observe that glycodelin A is inhibitory to T cells even upon phorbol ester and ionophore stimulation which bypasses the TCR-proximal signaling events, and that glycodelin A treatment does not interfere with T cell activation as evidenced from induction of the activation marker CD69. Thus, glycodelin A initiates mitochondrial stress-mediated apoptosis in T cells by a pathway that is distinct and independent from the TCR signaling pathway. 相似文献
445.
Siddharth Srivastava Mustafa Sahin Joseph D. Buxbaum Elizabeth Berry-Kravis Latha Valluripalli Soorya Audrey Thurm Jonathan A. Bernstein Afua Asante-Otoo William E. Bennett Jr Catalina Betancur Tegwyn H. Brickhouse Maria Rita Passos Bueno Maya Chopra Celanie K. Christensen Jennifer L. Cully Kira Dies Kate Friedman Brittany Gummere J. Lloyd Holder Jr Andres Jimenez-Gomez Carolyn A. Kerins Omar Khan Teresa Kohlenberg Ronald V. Lacro Lori A. Levi Tess Levy Diane Linnehan Loth Eva Baharak Moshiree Ann Neumeyer Scott M. Paul Katy Phelan Antonio Persico Robert Rapaport Curtis Rogers Jeffrey Saland Swathi Sethuram Janine Shapiro Phillip I. Tarr Kerry M. White Jordan Wickstrom Kent M. Williams Dana Winrow Brian Wishart Alexander Kolevzon 《American journal of medical genetics. Part A》2023,191(8):2015-2044
Phelan–McDermid syndrome (PMS) is a genetic condition caused by SHANK3 haploinsufficiency and characterized by a wide range of neurodevelopmental and systemic manifestations. The first practice parameters for assessment and monitoring in individuals with PMS were published in 2014; recently, knowledge about PMS has grown significantly based on data from longitudinal phenotyping studies and large-scale genotype–phenotype investigations. The objective of these updated clinical management guidelines was to: (1) reflect the latest in knowledge in PMS and (2) provide guidance for clinicians, researchers, and the general community. A taskforce was established with clinical experts in PMS and representatives from the parent community. Experts joined subgroups based on their areas of specialty, including genetics, neurology, neurodevelopment, gastroenterology, primary care, physiatry, nephrology, endocrinology, cardiology, gynecology, and dentistry. Taskforce members convened regularly between 2021 and 2022 and produced specialty-specific guidelines based on iterative feedback and discussion. Taskforce leaders then established consensus within their respective specialty group and harmonized the guidelines. The knowledge gained over the past decade allows for improved guidelines to assess and monitor individuals with PMS. Since there is limited evidence specific to PMS, intervention mostly follows general guidelines for treating individuals with developmental disorders. Significant evidence has been amassed to guide the management of comorbid neuropsychiatric conditions in PMS, albeit mainly from caregiver report and the experience of clinical experts. These updated consensus guidelines on the management of PMS represent an advance for the field and will improve care in the community. Several areas for future research are also highlighted and will contribute to subsequent updates with more refined and specific recommendations as new knowledge accumulates. 相似文献
446.
Objective: Clitoria ternatea is a well-known bioactive plant used to treat several inflammatory ailments in Ayurvedic system of medicine in India. The present investigation aimed to determine the anti-inflammatory and anti-arthritic activity of ethanolic extract of Clitoria ternatea roots (EECT) in animal models.
Methods: The anti-inflammatory activity of the EECT was evaluated by carrageenan and histamine-induced paw edema.
Results: EECT showed a significant reduction in mean paw edema volume in both carrageenan and histamine-induced inflammation. The efficacy of EECT in rheumatoid arthritis was tested against Freund’s complete adjuvant (CFA) induced arthritic models in Wistar rats. The anti-arthritic effect of EECT was determined by systematic scoring of arthritis symptoms and measuring paw edema. A considerable decrease in paw diameter was observed in the EECT (200 and 400 mg/kg) and diclofenac (10 mg/kg) treated groups after day 7. Diclofenac (10 mg/kg) and EECT (400 mg/kg) showed a significant reduction in paw diameter from day 14 compared with CFA control (P < 0.001). The anti-arthritic activity was also confirmed from the altered biochemical, haematological (Hb, RBC and WBC) and anti-oxidant parameters (SOD, MDA, CAT, and GSH). EECT (400 and 200 mg/kg) also showed a marked inhibition of joint destruction.
Conclusion: This study provides a pharmacological rationale for the traditional use of C. ternatea against inflammation and rheumatoid arthritis in India. 相似文献
447.
448.
449.
Mitchell Corey Sanders PhD Swathi Balaji PhD W. Blake Martin PhD Nikole Siegmund BS Lindsay Poland MS Mia Sanders Hanna BA Da Wei PhD Hanna Kaliada BS Sara Littlejohn BS Timothy Ganey PhD 《Wound repair and regeneration》2023,31(4):475-488
Recent evidence suggests that protecting human amnion and chorion matrices (HACM) during processing enhances the performance of HACM for wound repair and tissue regeneration. We utilised a diabetic (db/db) delayed wound healing mouse model. Treatment of db/db full-thickness excisional wounds with HACM, processed with a polyampholyte preservative accentuated the proliferative phase of wound healing that decreased the time necessary to heal wounds. Polyampholyte protection improved the preservation of growth factors and cytokines during room temperature storage following E-beam sterilisation and improved its function in wound healing applications. Our findings indicate protected HACM tissue up-regulated MIP2, NF-kB, TNF-α, KI-67, and Arg1 (0.6-fold to 1.5-fold) but those changes were not statistically significant. Immunofluorescent assessment identifying cell activity illustrated an induction of the proliferative phase of wound healing and a switch from an inflammatory macrophage phenotype (M1) to a pro-regenerative macrophage phenotype (M2a). Genomic profiling of 282 genes was performed using Nanostring from co-cultures of human macrophages and fibroblasts. The polyampholyte + HACM-treated group, compared with the HACM or polyampholyte alone groups, had a statistically significant up-regulation (32–368 fold) of 12 genes primarily involved in macrophage plasticity including CLC7, CD209, CD36, HSD11B1, ICAM1, IL1RN, IL3RA, ITGAX, LSP1, and PLXDC2 (adj. p-value < 0.05). The polyampholyte alone group demonstrated statistically significant down-regulation of four genes ADRA2, COL7A1, CSF3, and PTGS2 (adj. p < 0.05). The HACM alone group up-regulated four genes ATG14, CXCL11, DNMT3A, and THBD, but the results were not statistically significant. Biomechanical measurements indicated that wounds treated with polyampholyte-protected HACM had more tensile integrity compared with wounds treated with HACM alone. These findings indicate that better protection of HACM during processing stabilises the HACM matrix, which may lead to improved wound healing outcomes. 相似文献